A randomized trial of pivanex [AN 9] plus docetaxel or docetaxel monotherapy in patients with chemotherapy resistant advanced non-small cell carcinoma of the lung (NSCLC)
Phase of Trial: Phase II
Latest Information Update: 10 Sep 2005
At a glance
- Drugs AN 9; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Sep 2005 New trial record.